TSY-110 is positioned to become the first biosimilar alternative to Roche's Kadcyla® (ado-trastuzumab emtansine) in major regulated markets. TAIPEI, Aug....

SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business...

SYDNEY, Aug. 28, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies...

NANJING, China, Aug. 28, 2026 /PRNewswire/ -- InxMed Co., Ltd ("InxMed"), a clinical-stage biotechnology company dedicated to developing innovative therapies...

SINGAPORE, Aug. 28, 2026 /PRNewswire/ -- Chris Kelly, Senior Vice President of Data Center Solutions, Asia Pacific, Japan and Greater...

BEIJING, Aug. 28, 2026 /PRNewswire/ -- InfiMaker, which received an exclusive lead investment from Kunlun Capital in its angel round...

HANGZHOU, China, Aug. 28, 2026 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ / 3347.HK), a leading global provider of...

Zhongguancun Zhongnuo Fund Backs International Commercialization, Platform Development and Partner Deployment SHENZHEN, China, Aug. 28, 2026 /PRNewswire/ -- Warpify Technology...

The renovated court at Communal Elementary School opens a dedicated space for learning, sport, and community life in Buhangin. DAVAO...

The annual joint event between the PPA Tour and PPA Tour Australia heads to the iconic Queensland Tennis Centre, home...